View More Recent Stories
-
Piper Sandler Reiterates Overweight Rating on Edgewise Therapeutics (EWTX)
-
Here's the list of biotech stocks that have key data catalysts in 2025
-
Piper Sandler Reiterates Overweight Rating on Edgewise Therapeutics (EWTX)
-
Edgewise Therapeutics, Inc. (EWTX) Tops Q2 EPS by 1c
-
RBC's biotech survey shows investors more bearish vs. last time
-
2Q24 U.S. biotech earnings preview
-
Piper Sandler Reiterates Overweight Rating on Edgewise Therapeutics (EWTX)
-
Edgewise Therapeutics Inc. (EWTX) Added to Wedbush Best Ideas List

